1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Sato, M. Tochio, N. Koshiba, S. Inoue, M. Kigawa, T. Yokoyama, S. RIKEN Structural Genomics/Proteomics Initiative (RSGI) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Solution structures of the fn3 domain of human ephrin type-B receptor 1 10.2210/pdb2djs/pdb pdb_00002djs 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 11804.199 Ephrin type-B receptor 1 2.7.1.112 Fibronectin type III domain 1 man polymer Tyrosine-protein kinase receptor EPH-2, NET, HEK6, ELK no no GSSGSSGPSTVPIMHQVSATMRSITLSWPQPEQPNGIILDYEIRYYEKEHNEFNSSMARSQTNTARIDGLRPGMVYVVQV RARTVAGYGKFSGKMCFQTLTDSGPSSG GSSGSSGPSTVPIMHQVSATMRSITLSWPQPEQPNGIILDYEIRYYEKEHNEFNSSMARSQTNTARIDGLRPGMVYVVQV RARTVAGYGKFSGKMCFQTLTDSGPSSG A hso002001071.1 polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample Cell-free protein synthesis EPHB1 9606 Homo sapiens Cell free synthesis PLASMID P050912-11 RIKEN Structural Genomics/Proteomics Initiative RSGI NPPSFA, National Project on Protein Structural and Functional Analyses database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2006-10-05 1 1 2008-04-30 1 2 2011-07-13 1 3 2022-03-09 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details Y PDBJ Y PDBJ 2006-04-05 REL REL target function, structures with the least restraint violations 100 20 3D_13C-separated_NOESY 3D_15N-separated_NOESY 120mM 7.0 ambient 296 K torsion angle dynamics 1 lowest energy 1mM fn3 domain U-15N, 13C; 20mM d-Tris HCl; 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 10% D2O 90% H2O/10% D2O Bruker collection XwinNMR 3.5 Delaglio, F. processing NMRPipe 20031121 Johnson, B.A. data analysis NMRView 5.0.4 Kobayashi, N. data analysis KUJIRA 0.932 Guntert, P. structure solution CYANA 2.0.17 Guntert, P. refinement CYANA 2.0.17 900 Bruker AVANCE GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A SER 3 n 3 SER 3 A GLY 4 n 4 GLY 4 A SER 5 n 5 SER 5 A SER 6 n 6 SER 6 A GLY 7 n 7 GLY 7 A PRO 8 n 8 PRO 8 A SER 9 n 9 SER 9 A THR 10 n 10 THR 10 A VAL 11 n 11 VAL 11 A PRO 12 n 12 PRO 12 A ILE 13 n 13 ILE 13 A MET 14 n 14 MET 14 A HIS 15 n 15 HIS 15 A GLN 16 n 16 GLN 16 A VAL 17 n 17 VAL 17 A SER 18 n 18 SER 18 A ALA 19 n 19 ALA 19 A THR 20 n 20 THR 20 A MET 21 n 21 MET 21 A ARG 22 n 22 ARG 22 A SER 23 n 23 SER 23 A ILE 24 n 24 ILE 24 A THR 25 n 25 THR 25 A LEU 26 n 26 LEU 26 A SER 27 n 27 SER 27 A TRP 28 n 28 TRP 28 A PRO 29 n 29 PRO 29 A GLN 30 n 30 GLN 30 A PRO 31 n 31 PRO 31 A GLU 32 n 32 GLU 32 A GLN 33 n 33 GLN 33 A PRO 34 n 34 PRO 34 A ASN 35 n 35 ASN 35 A GLY 36 n 36 GLY 36 A ILE 37 n 37 ILE 37 A ILE 38 n 38 ILE 38 A LEU 39 n 39 LEU 39 A ASP 40 n 40 ASP 40 A TYR 41 n 41 TYR 41 A GLU 42 n 42 GLU 42 A ILE 43 n 43 ILE 43 A ARG 44 n 44 ARG 44 A TYR 45 n 45 TYR 45 A TYR 46 n 46 TYR 46 A GLU 47 n 47 GLU 47 A LYS 48 n 48 LYS 48 A GLU 49 n 49 GLU 49 A HIS 50 n 50 HIS 50 A ASN 51 n 51 ASN 51 A GLU 52 n 52 GLU 52 A PHE 53 n 53 PHE 53 A ASN 54 n 54 ASN 54 A SER 55 n 55 SER 55 A SER 56 n 56 SER 56 A MET 57 n 57 MET 57 A ALA 58 n 58 ALA 58 A ARG 59 n 59 ARG 59 A SER 60 n 60 SER 60 A GLN 61 n 61 GLN 61 A THR 62 n 62 THR 62 A ASN 63 n 63 ASN 63 A THR 64 n 64 THR 64 A ALA 65 n 65 ALA 65 A ARG 66 n 66 ARG 66 A ILE 67 n 67 ILE 67 A ASP 68 n 68 ASP 68 A GLY 69 n 69 GLY 69 A LEU 70 n 70 LEU 70 A ARG 71 n 71 ARG 71 A PRO 72 n 72 PRO 72 A GLY 73 n 73 GLY 73 A MET 74 n 74 MET 74 A VAL 75 n 75 VAL 75 A TYR 76 n 76 TYR 76 A VAL 77 n 77 VAL 77 A VAL 78 n 78 VAL 78 A GLN 79 n 79 GLN 79 A VAL 80 n 80 VAL 80 A ARG 81 n 81 ARG 81 A ALA 82 n 82 ALA 82 A ARG 83 n 83 ARG 83 A THR 84 n 84 THR 84 A VAL 85 n 85 VAL 85 A ALA 86 n 86 ALA 86 A GLY 87 n 87 GLY 87 A TYR 88 n 88 TYR 88 A GLY 89 n 89 GLY 89 A LYS 90 n 90 LYS 90 A PHE 91 n 91 PHE 91 A SER 92 n 92 SER 92 A GLY 93 n 93 GLY 93 A LYS 94 n 94 LYS 94 A MET 95 n 95 MET 95 A CYS 96 n 96 CYS 96 A PHE 97 n 97 PHE 97 A GLN 98 n 98 GLN 98 A THR 99 n 99 THR 99 A LEU 100 n 100 LEU 100 A THR 101 n 101 THR 101 A ASP 102 n 102 ASP 102 A SER 103 n 103 SER 103 A GLY 104 n 104 GLY 104 A PRO 105 n 105 PRO 105 A SER 106 n 106 SER 106 A SER 107 n 107 SER 107 A GLY 108 n 108 GLY 108 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N HIS 15 A N HIS 15 A O SER 27 A O SER 27 A N ILE 24 A N ILE 24 A O ILE 67 A O ILE 67 A O ALA 58 A O ALA 58 A N ILE 43 A N ILE 43 A N GLU 42 A N GLU 42 A O ARG 81 A O ARG 81 A N ALA 82 A N ALA 82 A O GLY 89 A O GLY 89 A O ALA 58 A O ALA 58 A N ILE 43 A N ILE 43 A N GLU 42 A N GLU 42 A O ARG 81 A O ARG 81 A N TYR 76 A N TYR 76 A O PHE 97 A O PHE 97 1 A SER 9 -56.91 -174.87 1 A ALA 19 -173.92 145.66 1 A GLN 33 -118.43 56.05 1 A PRO 34 -69.75 0.38 1 A ASP 102 -98.08 43.42 2 A PRO 34 -69.72 2.41 2 A SER 103 -125.84 -56.75 3 A SER 9 -59.85 -179.31 3 A GLN 33 -118.55 53.20 3 A PRO 34 -69.75 1.97 3 A LYS 94 -40.67 155.44 4 A SER 3 -56.91 105.67 4 A SER 9 -48.80 175.46 4 A ALA 19 -171.72 142.69 4 A PRO 34 -69.75 0.43 4 A ASN 35 42.07 25.04 4 A ILE 37 -37.63 141.85 4 A ASN 54 -78.56 49.21 4 A SER 103 -173.98 149.64 4 A SER 106 34.62 47.53 5 A PRO 34 -69.76 0.42 5 A ASN 35 45.73 29.36 6 A SER 9 -64.73 -179.46 6 A GLN 33 -119.95 53.83 6 A ILE 37 -52.27 107.75 6 A ASN 54 -104.56 61.42 6 A SER 107 -59.76 176.66 7 A SER 5 -41.62 154.86 7 A SER 9 -50.94 175.69 8 A SER 2 -36.64 105.74 8 A SER 9 -51.94 175.57 8 A PRO 34 -69.76 2.57 8 A ASN 54 -94.76 48.78 8 A PRO 105 -69.73 -178.68 8 A SER 106 -173.36 145.55 9 A SER 2 -88.71 42.44 9 A ALA 19 -175.03 145.75 9 A PRO 34 -69.75 0.83 9 A ASN 35 42.79 25.31 9 A ILE 37 -39.97 134.46 9 A ASP 102 -86.90 39.44 10 A ALA 19 -172.30 146.59 10 A PRO 29 -69.75 -179.45 10 A GLN 33 -119.55 51.11 10 A PRO 34 -69.81 2.35 10 A SER 107 -55.78 176.17 11 A SER 9 -56.88 171.08 12 A GLN 33 -119.55 50.41 12 A PRO 34 -69.78 2.40 12 A ASN 54 -104.36 53.93 13 A SER 9 -46.16 158.61 13 A ALA 19 -174.73 146.73 13 A GLN 33 -118.29 50.58 13 A ASN 54 -92.80 51.95 13 A SER 106 -103.78 41.97 14 A SER 9 -57.87 174.34 14 A PRO 34 -69.70 0.80 14 A ILE 37 -39.13 143.22 14 A GLU 47 -36.36 122.88 14 A ASN 54 -104.63 55.11 14 A LYS 94 -38.01 132.20 14 A THR 99 -61.73 -179.71 15 A SER 2 -65.47 94.31 15 A SER 9 -48.99 176.58 15 A VAL 11 -36.39 138.06 15 A GLN 33 -118.80 56.87 15 A ILE 37 -56.15 105.10 15 A ASN 54 -102.58 66.11 16 A SER 9 -55.47 -177.22 16 A PRO 34 -69.81 2.97 16 A GLU 47 -38.31 140.22 16 A ASN 54 -102.58 41.37 17 A SER 6 37.86 33.99 17 A SER 9 -48.73 161.25 17 A PRO 34 -69.75 2.40 17 A ASN 35 48.99 28.32 17 A SER 103 36.86 37.84 18 A SER 3 -173.64 113.96 18 A SER 6 -59.27 106.10 18 A SER 9 -47.48 168.15 18 A LYS 94 -37.76 131.77 18 A ASP 102 -83.03 47.66 18 A SER 103 -94.82 -66.98 19 A SER 9 -59.41 -176.29 19 A PRO 34 -69.73 2.09 19 A ASN 35 48.13 27.50 19 A ILE 37 -57.17 107.16 20 A SER 9 -48.13 172.59 20 A ALA 19 -174.46 149.04 20 A PRO 34 -69.81 0.90 20 A ASN 35 46.65 29.01 Solution structures of the fn3 domain of human ephrin type-B receptor 1 1 N N SIGNALING PROTEIN Tyrosine-protein kinase receptor EPH-2, NET, HEK6, ELK, Structural Genomics, NPPSFA, National Project on Protein Structural and Functional Analyses, RIKEN Structural Genomics/Proteomics Initiative, RSGI, SIGNALING PROTEIN EPHB1_HUMAN UNP 1 434 P54762 434 528 2DJS 8 102 P54762 A 1 8 102 1 cloning artifact GLY 1 2DJS A P54762 UNP 1 1 cloning artifact SER 2 2DJS A P54762 UNP 2 1 cloning artifact SER 3 2DJS A P54762 UNP 3 1 cloning artifact GLY 4 2DJS A P54762 UNP 4 1 cloning artifact SER 5 2DJS A P54762 UNP 5 1 cloning artifact SER 6 2DJS A P54762 UNP 6 1 cloning artifact GLY 7 2DJS A P54762 UNP 7 1 cloning artifact SER 103 2DJS A P54762 UNP 103 1 cloning artifact GLY 104 2DJS A P54762 UNP 104 1 cloning artifact PRO 105 2DJS A P54762 UNP 105 1 cloning artifact SER 106 2DJS A P54762 UNP 106 1 cloning artifact SER 107 2DJS A P54762 UNP 107 1 cloning artifact GLY 108 2DJS A P54762 UNP 108 3 4 4 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A HIS 15 A HIS 15 A ALA 19 A ALA 19 A SER 23 A SER 23 A SER 27 A SER 27 A THR 64 A THR 64 A ASP 68 A ASP 68 A SER 56 A SER 56 A SER 60 A SER 60 A ILE 38 A ILE 38 A GLU 47 A GLU 47 A VAL 75 A VAL 75 A THR 84 A THR 84 A TYR 88 A TYR 88 A PHE 91 A PHE 91 A SER 56 A SER 56 A SER 60 A SER 60 A ILE 38 A ILE 38 A GLU 47 A GLU 47 A VAL 75 A VAL 75 A THR 84 A THR 84 A MET 95 A MET 95 A GLN 98 A GLN 98